Back to search

University of Edinburgh

Characterisation of the respiratory syncytial virus seasonality and its preventive strategies in the Americas as tools for health policies

Abstract

dc:description.abstract

INTRODUCTION: Respiratory Syncytial Virus (RSV) is a leading cause of bronchiolitis and pneumonia among young children. Its fluctuating seasonality challenges the planning and timing of preventive strategies, especially across the Americas, where climate and geography drive regional variability, particularly in the tropics. Effective RSV prevention requires understanding both internal (host) factors and external (viral circulation) to optimise the timing of RSV immunoprophylaxis, including maternal immunisation and long-acting monoclonal antibodies (mAb). This thesis aimed to characterise RSV seasonal patterns in the Americas in relation to environmental variables and seasonal influenza patterns (study 1), assess their implications for the timing of passive immunisation across birth cohorts and settings (study 2), and estimate the averted burden of RSV-related illnesses to tailor regional immunisation policy (study 3). METHODS: Using surveillance data reported from 2010 to 2019 from a multi-country regional respiratory surveillance network, the first study analysed RSV seasonality across 32 countries, its association with environmental variables, and its relationship with influenza circulation. Time-series decomposition, and three independent seasonality methods (Negative Binomial, Moving Epidemics Method, and WHO Moving Averages Models) were used to define the onset, peak, and duration of activity. Correlation and regression analyses examined associations with environmental and influenza predictors. The second study modelled the optimal timing and potential impact of RSV passive immunisation for birth cohorts in Latin America and the Caribbean, accounting for RSV seasonality, duration of protection (assumed to be 5-6 months for long-acting monoclonal antibodies and approximately 6 months for maternal RSV immunisation), uptake and intervention windows. Newborns eligible for passive RSV immunisation were identified based on different assumptions regarding protection duration and strategies. A third study evaluated the estimated impact of alternative nirsevimab deployment strategies by adapting a static impact model to estimate the annual reduction in RSV-associated acute lower respiratory infections (ALRI), including hospitalisations, outpatient visits and total illnesses. Chile was used as a case study for the 2023-2024 period. Model parameters included annual newborn cohorts, RSV-ALRI admission rates, RSV test positivity, and assumed immunisation uptake. Reductions in RSV-associated disease burden were estimated independently for each year under varying immunisation timing and coverage levels, using a hypothetical no-intervention scenario as the counterfactual. RESULTS: During 2010-2019, 32 countries in the Americas reported 14,308,503 respiratory samples, of which 446,648 (3.12%) were RSV-positive. RSV annual epidemics progressed from south to north, with onset ranging from March to November in subtropical regions and year-round epidemics in tropical settings. In South America, seasons began in early May and peaked in August, while in the Caribbean, activity started in September and peaked in October and November. Central America’s RSV season lagged behind influenza, whereas in the Andes it peaked earlier. Higher latitudes exhibited earlier and shorter RSV epidemics. RSV circulation was negatively associated with temperatures (-0.43; p<0.0001), and precipitation (-0.04; p=0.0035), and positively associated with longitude (0.12; p<0.0001), barometric pressure (0.15; p<0.0001), elevation (0.02; p=0.10), and more westerly locations (0.12; p<0.0001). Seasonal immunisation benefited infants born during January-September in temperate countries, while year-round births in tropical countries benefited from protection during at least one epidemic. Year-round immunisation strategies were more suitable for the tropics. At 80% coverage, mAb prevented 61.3% (95% CI: 60.7; 67) and 55% (95% CI: 55.0; 56.0) of RSV-ALRI cases among infants 0-<12 months in temperate and tropical countries, respectively. In subtropical regions, combined RSV maternal vaccination and long-acting mAb averted 57.3% (95% CI: 56.8; 57.8) of RSV-ALRI cases. Efficiency per 100,000 doses administered varied minimally across strategies. During 2023-2024, Chile's sentinel surveillance reported RSV positivity of 19.1% among SARI cases among infants under twelve months (1,100 of 5,791 cases). The model estimated that under a baseline nirsevimab deployment (90% uptake, April-October), approximately 22.5% (95% CI: 16.9; 29.5) of RSV-associated ALRI cases would have been averted in 2023. Earlier deployment and achieving 100% coverage, individually or combined, would have increased reductions to up to 53.8% of annual RSV-associated ALRI cases (95% CI: 40.4; 70.5). Immunisation strategies aligned with peak RSV circulation were associated with greater averted burden. CONCLUSION: Subregional and interannual variations in RSV seasonality are influenced by environmental factors, underscoring the need for strengthened surveillance to tailor the optimal timing of preventive campaigns. RSV seasonality and adapted impact models provide authorities with tools to assess the annual impact of RSV interventions and inform policy decisions. In Chile, newborn passive immunisation likely prevented substantial RSV hospitalisations and illnesses. Adapted models enable policymakers to assess the annual impact of RSV interventions through surveillance, providing a scalable tool for timely, evidence-driven policy-making across the region.

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Couto, Paula Verónica
Advisors dc:contributor.advisor
  • Nair, Harish
  • Campbell, Harry
  • Li, You

Subjects

dc:subject × 5

Rights

Language dc:language.iso
en

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
University of Edinburgh
Base URL
era.ed.ac.uk/server/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Couto, Paula Verónica. Characterisation of the respiratory syncytial virus seasonality and its preventive strategies in the Americas as tools for health policies. 2026. https://era.ed.ac.uk/handle/1842/44846